Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2016

Feb 1, 2016

34519_dirs_2016-02-01_f7a74655-708e-432c-9ce7-ba03d108bfed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2016-01-29

Reporting Person: Cunningham David (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-01-29 Common Stock, par value $0.10 per share P 1904.0000 $5.2500 Acquired 7404.0000 Direct